Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
KOREA DISEASE CONTROL AND PREVENTION AGENCY, NATIONAL INSTITUTE OF HEALTH has floated a tender for [Academic] Phase 1 Clinical Study on 3Rd Generation Smallpox/Monkeypox Vaccine Kvac103. The project location is South Korea and the tender is closing on 06 Mar 2024. The tender notice number is 20240122232-00, while the TOT Ref Number is 95655208. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : South Korea
Summary : [Academic] Phase 1 Clinical Study on 3Rd Generation Smallpox/Monkeypox Vaccine Kvac103
Deadline : 06 Mar 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 95655208
Document Ref. No. : 20240122232-00
Competition : NCB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : KRW 2863636364
Purchaser's Detail
Purchaser : KOREA DISEASE CONTROL AND PREVENTION AGENCY, NATIONAL INSTITUTE OF HEALTH
Republic of Korea
Name: Jeong-eon Kim
Phone number: 043-719-8137
[Disclaimer: Please refer to the bidding notice for details on the exact organization/bidding body.]
South Korea
Email :scocoa1@korea.kr
Tender Details
[Academic] Phase 1 clinical study on 3rd generation smallpox/monkeypox vaccine KVAC103
Reference number: National Institute of Health Notice No. 2024-127
Allocation budget: KRW 3, 150, 000, 000
Estimated price: KRW 2, 863, 636, 364
(Value-added tax: KRW 286, 363, 636)
Bidding start date: 2024/01/23 10:00:00
Bidding closing date and time : 2024/03/06 10:00:00e5de163d51c4c382d83d4bcdcc430e25
Documents
Want To Bid in This Tender?
Get Local Agent Support in South Korea and 60 More Countries.
View Tenders By
Sign in with Google